ORTOMA AB B (82Y) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ORTOMA AB B (82Y) has a cash flow conversion efficiency ratio of -0.120x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.13 Million ≈ $-20.03 Million USD) by net assets (€142.72 Million ≈ $166.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of ORTOMA AB B to measure how many days the company can operate on defensive assets alone.
ORTOMA AB B - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how ORTOMA AB B's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ORTOMA AB B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ORTOMA AB B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aquirian Ltd
AU:AQN
|
0.062x |
|
Beamtree Holdings Ltd
AU:BMT
|
0.011x |
|
TDb Split Corp
TO:XTD
|
-0.045x |
|
Dcon Products Public Company Limited
BK:DCON
|
0.001x |
|
NIGHTINGALE HEALTH EO 1
F:7XE
|
N/A |
|
Citigold Corporation Ltd
AU:CTO
|
-0.008x |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
0.016x |
|
Alpha Trust Andromeda Investment Trust S.A
AT:ANDRO
|
0.109x |
Annual Cash Flow Conversion Efficiency for ORTOMA AB B (2021–2025)
The table below shows the annual cash flow conversion efficiency of ORTOMA AB B from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see ORTOMA AB B market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €142.72 Million ≈ $166.85 Million |
€6.04 Million ≈ $7.06 Million |
0.042x | +131.12% |
| 2024-12-31 | €161.91 Million ≈ $189.29 Million |
€-22.01 Million ≈ $-25.73 Million |
-0.136x | -276.65% |
| 2023-12-31 | €173.54 Million ≈ $202.88 Million |
€13.35 Million ≈ $15.61 Million |
0.077x | +206.13% |
| 2022-12-31 | €114.29 Million ≈ $133.62 Million |
€-8.29 Million ≈ $-9.69 Million |
-0.073x | +37.94% |
| 2021-12-31 | €130.04 Million ≈ $152.03 Million |
€-15.19 Million ≈ $-17.76 Million |
-0.117x | -- |
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more